Job Description Req #: 1900766
Location: Summit, New Jersey, United States
Job Category: General
Work Location: 86 Morris Avenue 07901
Employee Status: Full-time
Job Type: Regular
Work closely with Business Partners to support and deliver system solutions to the Business, in the area of IT Manufacturing and Supply-Chain. Provide techno-functional support and analyze Manufacturing & Supply Chain systems to recommend improved effectiveness and efficiency. Act as the liaison between cross-functional groups by planning, conducting, and directing the analysis of highly complex business problems to be solved through IT solutions. Ensure end to end understanding of Business Processes and systems solutions. Lead projects and requirements development, functional design and Technical Design, and provide recommendations on Technology solutions to address business needs. Configure and test Oracle Applications 12 e-Business Suite: Oracle Inventory (INV), Bills of Material (BOM), Process manufacturing, Discrete Manufacturing, Order Management (OM) and Advanced Pricing. Develop and document detailed program specifications, business process models and scenarios. Determine the technical, interfacing and operational requirements to resolve Oracle EBS Software issues. Lead configuration and administration of the Oracle EBS software as per business and technical requirements. Participate in post-production software support and problem resolution. Some international and domestic travel required.
COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.
Celgene is a biopharmaceutical company.